Antihypertensive agents with long half-lives, such as telmisartan, may be beneficial in blunting the early morning blood pressure surge associated with increased cardiovascular events.
Authors
No takes yet. Share an insight, caveat, or question.
May support long-acting antihypertensives for morning BP surge; leaves open outcome benefits in prospective trials.
Josep Redón (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: